Education
About Us
Working with TipRanks
Follow Us
Gary Wayne Hayes Insider Profile
4 Followers
Gary Wayne Hayes, Director at Advanced Proteome Therapeutics, holds 678.95K shares in Advanced Proteome Therapeutics (Ticker: TSE:APC.H).
Gary Wayne Hayes Advanced Proteome Therapeutics (APC.H)Director
Advanced Proteome Therapeutics (APC.H)
Director
Ranked #31,113 out of 106,131 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+60.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Gary Wayne Hayes does not currently own shares as a corporate insider.
A breakdown of Gary Wayne Hayes's holdings
Insider Roles
Gary Wayne Hayes does not currently hold a role as a corporate insider.
Roles that Gary Wayne Hayes holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Gary Wayne Hayes
Gary Wayne Hayes's Trading History
List of latest transactions for each holding click on a transaction to see Gary Wayne Hayes's performance on stock
You May Also Like
Gary Wayne Hayes insider profile FAQ
What is the percentage of profitable transactions made by Gary Wayne Hayes?
The percentage of profitable transactions made by Gary Wayne Hayes is 100%.
What is the average return per transaction made by Gary Wayne Hayes?
The average return per transaction made by Gary Wayne Hayes is 60.00%.
What stocks does Gary Wayne Hayes hold?
Gary Wayne Hayes holds: TSE:APC.H stocks.
What was Gary Wayne Hayes’s latest transaction?
Gary Wayne Hayes latest transaction was an Uninformative Sell of C$41.63K.
What was Gary Wayne Hayes's most profitable transaction?
Gary Wayne Hayes’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Gary Wayne Hayes's role in Advanced Proteome Therapeutics?
Gary Wayne Hayes's role in Advanced Proteome Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.